The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug manufacturer announced on Tuesday that the company would begin shipping orforglipron,

FDA approves Eli Lilly’s daily weight‑loss pill Foundayo, a fast‑tracked GLP‑1 drug offering a new oral option for obesity treatment.

The U.S. Food and Drug Administration has approved Eli Lilly's weight-loss pill, bringing another oral alternatives to a market dominated by injectables and intensifying competition with Novo ​Nordisk ,

Merck & Co.’s experimental cholesterol pill slashed levels of the artery-clogging plaque far more than older tablets in the latest study to show it may rival powerful injections for high-risk patients.

If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's a new option that might be even more appealing: a once-daily pill. The FDA recently approved a Wegovy (semaglutide) pill for weight management,